Tekla Life Sciences Investors HQL:NYSE

RT Quote | NYSE | USD
Last | 10/26/21 EDT
21.27UNCH (UNCH)
Volume
74,099
52 week range
16.58 - 22.70
Loading...
  • Open21.28
  • Day High21.34
  • Day Low21.16
  • Prev Close21.20
  • 52 Week High22.70
  • 52 Week High Date08/26/21
  • 52 Week Low16.58
  • 52 Week Low Date11/02/20

Key Stats

  • Market Cap516.44M
  • Shares Out24.28M
  • 10 Day Average Volume0.06M
  • Dividend1.72
  • Dividend Yield8.09%
  • Beta0.90
  • YTD % Change7.7

KEY STATS

  • Open21.28
  • Day High21.34
  • Day Low21.16
  • Prev Close21.20
  • 52 Week High22.70
  • 52 Week High Date08/26/21
  • 52 Week Low16.58
  • 52 Week Low Date11/02/20
  • Market Cap516.44M
  • Shares Out24.28M
  • 10 Day Average Volume0.06M
  • Dividend1.72
  • Dividend Yield8.09%
  • Beta0.90
  • YTD % Change7.7

RATIOS/PROFITABILITY

  • EPS (TTM)5.13
  • P/E (TTM)4.15
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-3.671M
  • ROE (TTM)27.52%
  • Revenue (TTM)2.32M
  • Gross Margin (TTM)-126.18%
  • Net Margin (TTM)5,360.97%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date-
  • Ex Div Date08/26/2021
  • Div Amount0.43
  • Split Date-
  • Split Factor-

Latest On Tekla Life Sciences Investors

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Tekla Life Sciences Investors (the Fund) is a diversified closed-end management investment company. The Fund's investment objective is long-term capital appreciation through investment in the United States and foreign companies in the life sciences industry, including biotechnology, pharmaceutical, diagnostics, managed healthcare and medical equipment, hospitals, healthcare information technology and services, devices and supplies, agriculture, and environmental management....
Oleg Pohotsky J.D.
Non-Executive Chairman
Daniel Omstead Ph.D.
President
Address
100 FEDERAL STREET, 19TH FLOOR
Boston, MA
02109-4884
United States